F. Meyer

发表

Implementing the role of patient-navigator nurse at a university hospital centre.

I. Bairati, L. Fillion, Marie de Serres, 2006, Canadian oncology nursing journal = Revue canadienne de nursing oncologique.

Prognostic Significance of Cyclooxygenase-2 Overexpression in Glottic Cancer

B. Têtu, A. Fortin, I. Bairati, 2008, Clinical Cancer Research.

P53 point mutations in initial superficial bladder cancer occur only in tumors from current or recent cigarette smokers.

B. Têtu, L. Moore, F. Meyer, 2000, Carcinogenesis.

Predictors of circulating INTERLEUKIN-6 levels in head and neck cancer patients

I. Bairati, F. Meyer, S. Turcotte, 2018, Cancers of the Head & Neck.

Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers

A. Azad, I. Bairati, Geoffrey Liu, 2012, Cancer.

Neoadjuvant hormonal therapy before radical prostatectomy and risk of prostate specific antigen failure.

L. Lacombe, B. Têtu, I. Bairati, 1999, The Journal of urology.

Dietary vitamin D intake and serum 25‐hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients

A. Adjei, I. Bairati, Geoffrey Liu, 2011, International journal of cancer.

Insulin-like growth factor binding protein 2: an androgen-dependent predictor of prostate cancer survival.

L. Lacombe, F. Meyer, B. Inman, 2005, European urology.

Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial

P. Galan, S. Bertrais, S. Hercberg, 2005, International journal of cancer.

A Prospective Study of the Insulin-Like Growth Factor Axis in Relation with Prostate Cancer in the SU.VI.MAX Trial

P. Galan, S. Bertrais, S. Czernichow, 2005, Cancer Epidemiology Biomarkers & Prevention.

Lifetime occupational physical activity and incidental prostate cancer (Canada)

I. Bairati, L. Moore, F. Meyer, 2000, Cancer Causes & Control.

Prostate cancer: 4. Screening.

F. Meyer, Y. Fradet, 1998, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Downward trend in prostate cancer mortality in Quebec and Canada.

I. Bairati, L. Moore, F. Meyer, 1999, The Journal of urology.

Tumorigenic pathways in low‐stage bladder cancer based on p53, MDM2 and p21 phenotypes

François G. Meyer, L. Lacombe, B. Têtu, 2000, International journal of cancer.

Antihypertensive Drug Use and The Risk of Prostate Cancer (Canada)

I. Bairati, F. Meyer, F. Harel, 2004, Cancer Causes & Control.

VALIDATION OF A NOMOGRAM FOR PREDICTING DISEASE RECURRENCE FOLLOWING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER

M. Kattan, J. Eastham, T. Cangiano, 1999 .

Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia.

F. Vermassen, A. Gallino, M. Capogrossi, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Matrix metalloproteinase 9 is associated with Gleason score in prostate cancer but not with prognosis.

B. Têtu, F. Meyer, D. Trudel, 2010, Human pathology.

Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.

L. Lacombe, B. Têtu, L. Moore, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Dietary fat and prostate cancer survival

I. Bairati, L. Moore, F. Meyer, 1999, Cancer Causes & Control.

Quebec prostate cancer mortality dropped in 1996.

I. Bairati, L. Moore, F. Meyer, 1998, Cancer prevention & control : CPC = Prevention & controle en cancerologie : PCC.

Acute Adverse Effects of Radiation Therapy and Local Recurrence in Relation to Dietary and Plasma Beta Carotene and Alpha Tocopherol in Head and Neck Cancer Patients

A. Fortin, I. Bairati, F. Meyer, 2007, Nutrition and cancer.

A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer

I. Bairati, F. Meyer, M. Guitton, 2019, Journal of Otolaryngology - Head & Neck Surgery.

Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients.

J. Roy, É. Vigneault, A. Fortin, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumors.

F. Meyer, Y. Fradet, G. Bedard, 1997, The Journal of urology.

Serum Prognostic Markers in Head and Neck Cancer

I. Bairati, Geoffrey Liu, F. Meyer, 2010, Clinical Cancer Research.

Factors influencing parent satisfaction with preventive health services for the early detection of speech and language delay in preschool children

I. Bairati, F. Meyer, A. Sylvestre, 2011 .

Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors.

François G. Meyer, L. Lacombe, L. Moore, 1999, Human pathology.

A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.

J. Roy, É. Vigneault, A. Fortin, 2005, Journal of the National Cancer Institute.

Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long‐term effects on recurrence and mortality: A randomized trial among head and neck cancer patients

A. Fortin, I. Bairati, F. Meyer, 2007, International journal of cancer.

Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest

L. Moore, F. Meyer, Y. Fradet, 2000, Oncogene.

Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence.

François G. Meyer, C. Cordon-Cardo, L. Lacombe, 1999, The American journal of pathology.

Validation of Genetic Sequence Variants as Prognostic Factors in Early-Stage Head and Neck Squamous Cell Cancer Survival

A. Azad, I. Bairati, Geoffrey Liu, 2011, Clinical Cancer Research.

Expression of p21 predicts PSA failure in locally advanced prostate cancer treated by prostatectomy

L. Lacombe, L. Moore, F. Meyer, 2001 .

Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patients

A. Azad, A. Adjei, I. Bairati, 2013, International journal of cancer.

Dietary energy and nutrients in relation to preclinical prostate cancer.

I. Bairati, L. Moore, F. Meyer, 1997, Nutrition and cancer.

Membrane-type-1 matrix metalloproteinase, matrix metalloproteinase 2, and tissue inhibitor of matrix proteinase 2 in prostate cancer: identification of patients with poor prognosis by immunohistochemistry.

F. Meyer, D. Trudel, Y. Fradet, 2008, Human pathology.

Dietary fat and advanced prostate cancer.

François G. Meyer, I. Bairati, L. Moore, 1998, The Journal of urology.

Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer

A. Fortin, I. Bairati, F. Meyer, 2012, Supportive Care in Cancer.

Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer

A. Fortin, I. Bairati, F. Meyer, 2010, Cancer.

A. Fortin, I. Bairati, F. Meyer, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A genome-wide association study of non-HPV-related head and neck squamous cell carcinoma identifies prognostic genetic sequence variants in the MAP-kinase and hormone pathways.

P. Boutros, Daryl Waggott, J. Waldron, 2016, Cancer epidemiology.

Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review

D. Cescon, I. Bairati, Geoffrey Liu, 2008, Cancer Epidemiology Biomarkers & Prevention.

Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia.

F. Vermassen, A. Gallino, M. Capogrossi, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Double‐Blind, Randomized, Controlled Trial of Fish Oil Supplements in Prevention of Recurrence of Stenosis After Coronary Angioplasty

I. Bairati, F. Meyer, L. Roy, 1992, Circulation.

Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer

I. Bairati, L. Moore, F. Meyer, 2003, International journal of cancer.

Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy.

A. Fortin, I. Bairati, Geoffrey Liu, 2012, International journal of radiation oncology, biology, physics.

Factors Associated With Expressive and Receptive Language in French-Speaking Toddlers Clinically Diagnosed With Language Delay

I. Bairati, F. Meyer, C. Mérette, 2012 .

Antioxidant vitamins supplementation and mortality: A randomized trial in head and neck cancer patients

A. Fortin, I. Bairati, F. Meyer, 2006, International journal of cancer.

An immunohistochemical study

Dominique Trudel, Bernard Têtu, Yves Fradet, 2013 .

Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease.

R. Goeree, F. Meyer, D. Armstrong, 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

PSA screening and prostate cancer mortality.

I. Bairati, L. Moore, F. Meyer, 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Maintenance bacillus Calmette‐Guérin in high‐risk nonmuscle‐invasive bladder cancer

L. Lacombe, F. Meyer, Y. Fradet, 2008, Cancer.

Expression of p21 predicts PSA failure in locally advanced prostate cancer treated by prostatectomy.

L. Lacombe, L. Moore, F. Meyer, 1999, International journal of cancer.

Duration of neoadjuvant androgen deprivation therapy before radical prostatectomy and disease-free survival in men with prostate cancer.

L. Lacombe, I. Bairati, F. Meyer, 2001, Urology.

Systematic review of the literature on characteristics of late-talking toddlers.

I. Bairati, F. Meyer, Chantal Desmarais, 2008, International journal of language & communication disorders.

Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I-125 permanent implant brachytherapy for prostate cancer.

É. Vigneault, M. Gaudet, F. Meyer, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Three profiles of language abilities in toddlers with an expressive vocabulary delay: variations on a theme.

I. Bairati, F. Meyer, A. Sylvestre, 2010, Journal of speech, language, and hearing research : JSLHR.

Prediction of the outcome of children who had a language delay at age 2 when they are aged 4: Still a challenge

I. Bairati, F. Meyer, J. Leblond, 2018, International journal of speech-language pathology.

Prostatic intraepithelial neoplasia in TURP specimens and subsequent prostate cancer.

L. Lacombe, I. Bairati, F. Meyer, 2006, The Canadian journal of urology.

PSA screening: correlating noise with noise?

I. Bairati, L. Moore, F. Meyer, 2002 .

Charlson Comorbidity Index as a Predictor of Cancer Mortality Beyond 10 Years after Radical Prostatectomy

L. Lacombe, I. Bairati, K. Robitaille, 2019 .

Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review

D. Cescon, I. Bairati, Geoffrey Liu, 2008, Cancer Epidemiology Biomarkers & Prevention.

Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia.

F. Vermassen, A. Gallino, M. Capogrossi, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Effects of a fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery disease.

I. Bairati, F. Meyer, L. Roy, 1992, The Canadian journal of cardiology.